The Drugs for Neglected Diseases initiative

Examples include The Institute for One World Health, The Drugs for Neglected Diseases Initiative, and The Medicines for Malaria Venture. 

The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, nonprofit R D organization aiming to deliver new treatments for neglected diseases. In particular, these include sleeping sickness (human African trypanosomiasis), Chagas disease, leishmaniasis, filarial parasitic-worm infections, and pediatric HIV. The primary aim is to deliver a total of 11-13 new treatments by 2018. 

Collaborative drug discovery projects in the public domain normally focus on neglected tropical diseases (e.g., tuberculosis, malaria, and leishmaniasis) due to the evident medical need, the reduced competition, and associated intellectual property burden. The Medicines for Malaria Venture (MMV) [32] was the first to focus on malaria in a collaborative shion. MMV started in 1999 with initial funding (US 4 million) from the governments of Switzerland and the Netherlands, the UK Department for International Development, the World Bank, and the Rockefeller Foundation. 

---